Shizuoka, Japan

Tetsuji Ohno



 

Average Co-Inventor Count = 6.9

ph-index = 8

Forward Citations = 150(Granted Patents)


Location History:

  • Shizuoka-ken, JP (1996 - 1997)
  • Shimotogari, JP (1997)
  • Shizuoka, JP (1987 - 2000)
  • Sunto-gun, JP (1997 - 2014)

Company Filing History:


Years Active: 1987-2014

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Tetsuji Ohno: Innovator in Thiazole Derivatives

Introduction

Tetsuji Ohno, a prolific inventor based in Shizuoka, Japan, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 20 patents, Ohno is well-regarded for his expertise in developing methods for treating central nervous system diseases. His work is characterized by the exploration of thiazole derivatives, which highlight his dedication to advancing medicinal chemistry.

Latest Patents

Among his latest patents, Ohno has focused on thiazole derivatives for the treatment of central nervous system diseases. These patents specify innovative methods that involve administering compounds where 'n' is an integer ranging from 0 to 3. The derivatives include a five-membered aromatic heterocyclic group containing at least one oxygen atom, along with various substituents such as aryl or lower alkyl groups. The complexity of these formulations showcases Ohno's commitment to addressing intricate medical challenges through targeted therapeutic strategies.

Career Highlights

Tetsuji Ohno has built a reputable career working with leading organizations in the pharmaceutical industry. He has been associated with Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited, where he contributed to various innovative projects. His tenure at these companies underscores his capability to translate scientific research into practical applications that benefit public health.

Collaborations

Ohno has collaborated with esteemed colleagues such as Akira Karasawa and Kazuhiro Kubo, fostering a collaborative environment that promotes knowledge sharing and innovation. These partnerships have allowed him to leverage diverse expertise, further enhancing the potential for groundbreaking advancements in his field.

Conclusion

Tetsuji Ohno remains a vital figure in the realm of pharmaceutical inventions, particularly in the development of thiazole derivatives aimed at treating central nervous system diseases. His extensive patent portfolio and collaborative efforts reflect his unwavering commitment to innovation in the healthcare sector. Through his work, Ohno continues to inspire future generations of inventors to pursue advancements that can significantly impact patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…